Tag: #MedicalAffairs

  • Syneos Health Opens Global Life Sciences Centre in Hyderabad

    Syneos Health Opens Global Life Sciences Centre in Hyderabad

    Hyderabad, September 24, 2026 – In a major boost to India’s biopharmaceutical and technology landscape, Syneos Health, a leading fully integrated biopharmaceutical solutions organization, has officially inaugurated its new Global Life Sciences and Technology Centre in Hyderabad.

    Spanning an impressive 137,000 square feet, this state-of-the-art facility is now the company’s largest centre in Asia and its third-largest globally, signaling a massive vote of confidence in Hyderabad’s burgeoning life sciences ecosystem.

    Scale and Scope of the New Centre

    The newly opened facility is designed to be a powerhouse of innovation and operational excellence. Key highlights of the centre include:

    • Robust Initial Workforce: The centre launches with an initial team of over 700 highly skilled professionals, with aggressive plans for expansion in the coming years.
    • End-to-End Capabilities: The hub brings together diverse, high-value functions under one roof, including clinical development, commercialization, medical affairs, advanced technology, Artificial Intelligence (AI), and core corporate functions.
    • Global Leadership Presence: Unlike traditional offshore delivery centers, this facility will house global leaders and cross-functional teams working directly from Hyderabad to drive drug development and commercialization strategies for clients worldwide.

    A Strategic Shift: Beyond the Traditional Delivery Model

    This inauguration marks a pivotal evolution in how global life sciences companies view India. Syneos Health is actively positioning its Hyderabad hub not merely as a back-office support center, but as a strategic growth hub.

    By embedding global leadership and advanced AI/engineering capabilities locally, Syneos Health is leveraging India’s deep talent pool to co-create solutions, accelerate clinical timelines, and drive innovation for the global biopharma market.

    Leadership Perspectives

    The centre was inaugurated by D. Sridhar Babu, Minister for IT and Industries of Telangana, alongside a distinguished delegation of Syneos Health executives, including:

    • Mike Montello, Chief Digital and Information Officer
    • Tom Wollman, Head of Operational Excellence
    • Jinu Jose, General Manager, India and Strategic Growth Hubs
    • Harpreet Bedi, Chief Technology Officer
    • Madhuri Raya, Global Head, AI and Engineering and Technology Capability Centre

    Highlighting the synergy between the state’s vision and the company’s goals, Minister D. Sridhar Babu stated:

    “Hyderabad has built one of India’s strongest life sciences ecosystems and one of its deepest technology talent pools. The next opportunity is to bring these strengths together with AI. We are moving from a city where medicines are made and services are delivered to a city where the future of healthcare and life sciences is being built. With an end-to-end ecosystem spanning APIs, bulk drugs, generics, CDMO, vaccines, research and discovery, and a growing concentration of global healthcare and biotech GCCs, Hyderabad has the talent and depth to become a global testbed for AI-enabled life sciences.”

    Strategic Impact on Hyderabad’s Life Sciences Ecosystem

    The establishment of this centre reinforces Hyderabad’s position as the “Genome Valley” of India and a premier global destination for Global Capability Centres (GCCs) in healthcare. The strategic impacts include:

    1. High-Value Job Creation: Attracting top-tier talent in clinical research, data science, AI, and biopharma commercialization.
    2. AI and Tech Integration: Accelerating the adoption of Artificial Intelligence and advanced analytics in drug discovery and clinical trial management within the region.
    3. Ecosystem Validation: Further validating Hyderabad’s comprehensive life sciences value chain, which already spans active pharmaceutical ingredients (APIs), vaccines, contract development and manufacturing (CDMO), and cutting-edge R&D.

    Looking Ahead

    As Syneos Health scales its operations in Hyderabad, the centre is poised to become a critical nerve center for the company’s global operations. By fusing deep domain expertise in life sciences with cutting-edge technology and AI, Syneos Health is not just expanding its footprint—it is actively helping to build the future of global healthcare from the heart of India.

  • Sanofi Expands Hyderabad GCC, Adds Nearly 2,000 Jobs in India

    Sanofi Expands Hyderabad GCC, Adds Nearly 2,000 Jobs in India

    French pharmaceutical giant Sanofi is deepening its commitment to India with a major expansion of its Global Capability Centre (GCC) in Hyderabad. The company plans to add nearly 2,000 new jobs, increasing total headcount at the centre from over 2,600 employees to more than 4,500 professionals.

    The expansion reflects Sanofi’s long-term strategy to strengthen its global operations by leveraging India’s growing pool of high-skilled talent in research, technology, and digital innovation.


    Significant Investment to Support Growth

    The expansion will be backed by a multi-hundred-million-dollar investment, though the company has not specified an exact hiring timeline. This move builds on Sanofi’s 2024 commitment to invest €400 million (approximately $474.6 million) in its India GCC operations by the end of the decade.

    The investment signals a shift toward scaling high-value functions in India, positioning the Hyderabad centre as a critical part of Sanofi’s global ecosystem.


    Focus on Innovation and Advanced Capabilities

    The additional roles will span across several strategic domains, including:

    • Research & Development (R&D)
    • Artificial Intelligence (AI)
    • Data Innovation and Analytics
    • Medical Affairs
    • Commercial Capabilities
    • Corporate Functions

    This indicates that Sanofi’s Hyderabad centre is evolving beyond traditional support services into a global innovation hub that contributes directly to enterprise-wide strategy and transformation.


    India’s Growing GCC Ecosystem

    Sanofi’s expansion comes at a time when India’s Global Capability Centre ecosystem is witnessing rapid growth. According to Anarock:

    • India hosts more than 1,700 GCCs
    • These centres employ over 1.9 million professionals
    • The GCC market could grow to $105–110 billion by 2030
    • The number of centres may exceed 2,400 by the end of the decade

    What were once considered cost-efficient back-office operations have now transformed into innovation-led centres driving digital transformation, R&D, finance, and global operations.


    Hyderabad: A Strategic Pharma Hub

    Hyderabad has increasingly become a focal point for global life sciences and technology companies. The announcement precedes the city’s flagship biotechnology conference, BioAsia, where global pharmaceutical leaders such as Eli Lilly, Novo Nordisk, Merck, and Sanofi are expected to discuss research expansion and India’s pharmaceutical growth trajectory.

    The timing further underscores Hyderabad’s growing importance in global healthcare innovation.


    A Strategic Shift in Global Operations

    For Sanofi, the Hyderabad GCC is emerging as a cornerstone of its global strategy. As pharmaceutical companies rebalance supply chains and invest heavily in digital capabilities, India’s skilled workforce and strong ecosystem make it a preferred destination for long-term investment.

    This expansion not only strengthens Sanofi’s operational capabilities but also reinforces India’s position as a global hub for advanced research, AI, and pharmaceutical innovation.